Commercial development is underway for a third E. coli O157:H7 vaccine for cattle to help prevent human illnesses with a Nebraska field trial set to begin soon.
Two North American vaccines developed since 2010 have proven their effectiveness, but for various reasons, including cost, they remain in limited demand in
Continue Reading Nebraska feedlots prepare to test new European E. coli vaccine